Menu
Recruiting NCT06394817

Beijing Disability Risk and Ageing Monitoring Study

— Observational Age Problem Disability Death

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: No intervention.
Who it may be relevant to
Registry conditions: Age Problem, Disability, Death. Basic parameters: from 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

This is a community-based prospective cohort study in Beijing, China. The study has been initialized in 2023 and enrolled older residents. This study aims to develop disability risk assessment standards and an early warning model for older adults.

Detailed description

This is a community-based prospective cohort study. Individuals who aged 60 years or older, lived in the communities for more than 1 year, and signed the informed consent form were enrolled in the present study. The study has been initialized in 2023 and aimed to develop an early warning model and a series of disability risk assessment methods for older adults. This work consists of three steps as following. First, we will build a community-based cohort and thus set up a database. Second, an intelligence model for disability risk assessment will be developed using the database. Third, a series of procedures will be established according to the risk assessment model.

Interventions

  • Other No intervention
    No intervention

Primary outcome measures

  • The prevalence and incidence of functional disability using a population-based survey [Time frame: An average of 1 to 2 years]
  • The prevalence and incidence of mild cognitive impairment using a population-based survey [Time frame: An average of 1 to 2 years]
  • The prevalence and incidence of dementia using a population-based survey [Time frame: An average of 1 to 2 years]
  • The conversion rate of normal to mild cognitive impairment [Time frame: An average of 1 to 2 years]
  • The conversion rate of mild cognitive impairment to dementia [Time frame: An average of 1 to 2 years]
  • The genetic and environmental factors for mild cognitive impairment and dementia at genomic and expression levels [Time frame: An average of 1 to 2 years]
  • The biomarkers for normal, mild cognitive impairment, and dementia diagnosis [Time frame: An average of 1 to 2 years]
  • The prevalence and incidence of movement disorder using a population-based survey [Time frame: An average of 1 to 2 years]

Eligibility criteria

Inclusion criteria

  • Aged 60 years or older
  • Lived in the community for more than 1 year
  • Signed the informed consent form

Exclusion criteria

  • Cannot complete the survey

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

China · 1 center
  • Xuanwu Hospital, Capital Medical University — Beijing

Identifiers

NCT: NCT06394817 · 2022234

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗